Q3 2026 results · 4 November 2026

Novo's obesity drugs reached 5.6 million people, 75% more than a year ago.

5.6Mobesity patients reached, up 75%

$830Msales of the new Wegovy pill

$12.2Bsales, up 4% at constant currency

Source

Get a note when Novo Nordisk reports next.

Whatco sends a short notification with the number that matters, and the full story of the company is a tap away.